Schedule 13G ownership disclosure
Stoke Therapeutics Inc
Security class unavailable · CUSIP: 86150R107
Event date: 2019-06-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.6700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-19-009851
- Form type
- SC 13G
- Filer
- RTW INVESTMENTS, LP
- CIK
- CIK 1493215
- Filed
- Jun 28, 2019
- Reporting period
- Jun 19, 2019
- Description
- Schedule 13G beneficial ownership